ArticleMicrobiology spectrum2025
The N-terminus of the
George F Aranjuez, Om Patel, Dev Patel, Travis J Jewett
Abstract read
In one paragraphArticle in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
4 authors.
George F AranjuezImmunity and Pathogenesis Division, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, USA.ORCID 0000-0001-8253-4468 Om Patel *Immunity and Pathogenesis Division, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, USA.
Dev Patel *Immunity and Pathogenesis Division, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, USA.
Travis J JewettImmunity and Pathogenesis Division, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, USA.
Funding
Resource Component: Acquisition, maintenance and distribution of Drosophila stocksP40OD018537 · OD · TRUSTEES OF INDIANA UNIVERSITY · PI Annette L. Parks · 2014 to 2026
$13.5MMolecular Analysis of the Chlamydia trachomatis virulence factor TarpR01AI139242 · NIAID · UNIVERSITY OF CENTRAL FLORIDA · PI JEWETT, TRAVIS JAMES · 2019 to 2022
$2.3MDrosophila melanogaster as a model organism to study Chlamydia trachomatis early effectorsR21AI148999 · NIAID · UNIVERSITY OF CENTRAL FLORIDA · PI JEWETT, TRAVIS JAMES · 2020 to 2021
$398kNational Institute of Allergy and Infectious Diseases R21AI148999, R01AI139242NIAID NIH HHS R01 AI139242NIAID NIH HHS R21 AI148999NIH HHS P40 OD018537
6 · The paper itselfAbstract
IMPORTANCE: The survival of obligate intracellular bacteria like
Indexed as
Bacterial ProteinsChlamydia trachomatisDrosophila ProteinsHost-Pathogen InteractionsIntracellular Signaling Peptides and ProteinsProtein Serine-Threonine KinasesAnimalsChlamydia InfectionsDrosophila melanogasterHippo KinasesHippo Signaling PathwayHumansSignal TransductionTrans-ActivatorsYAP-Signaling ProteinsBacterial ProteinsDrosophila ProteinsHippo Kinaseshpo protein, DrosophilaIntracellular Signaling Peptides and ProteinsProtein Serine-Threonine KinasesTrans-ActivatorsYAP-Signaling ProteinsYki protein, Drosophilacell signalingChlamydia trachomatisDrosophilaeffector functionshost-pathogen interactions
Identifiers
PMID40062849
PMCPMC11960468
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390